Literature DB >> 34226264

Teleretina screening for diabetic retinopathy.

Daniel Rosenberg1, Jason Noble1, Varun Chaudhary2.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34226264      PMCID: PMC8248575          DOI: 10.1503/cmaj.202141

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.

Ophthalmic screening is essential for detection of diabetic retinopathy

Diabetes Canada recommends eye exams every 1–2 years upon diagnosis of type 2 diabetes.1 A systematic review found that an average of 175 (range 75–267) screening sessions are required to detect 1 case of sight-threatening diabetic retinopathy in patients without retinopathy at baseline.2

Teleretina screening is a viable adjunct to in-person screening

Teleretina screening involves digital transmission of ocular images obtained by a technician for remote evaluation by a specialist (Appendix 1, available at www.cmaj.ca/lookup/doi/10.1503/cmaj.202141/tab-related-content). Technicians typically require one-on-one training with a teleophthalmology expert to effectively capture images.3 High-level evidence shows > 95% sensitivity and specificity for detection of diabetic retinopathy using teleretina screening.1 Teleretina screening is associated with reduced costs relative to in-person assessment.3

Patients with diabetes are more likely to participate in remote screening than in-person visits

A recent meta-analysis found significantly greater patient attendance for teleretina screening compared with traditional in-person assessment (odds ratio 13.15, 95% confidence interval 8.01–21.61, p < 0.001).4 Patients in poor health with limited access to health care professionals have challenges attending in-person screening; these patients are a target demographic for teleretina assessment.1

Teleretina screening is not available or recommended for all patients

Current evidence-based guidelines for teleretina screening apply only to nonpregnant patients aged 12 years or older with type 2 diabetes.5 Occasionally, images obtained during telescreening may be deemed “ungradable,” requiring an in-person assessment.1 Conditions that may interfere with the digital photo acquisition include dense cataracts or corneal scars.6

Centralized teleretina referral systems are in development in Canada

Several teleretina clinics have been initiated across Canada.1 Primary care providers are encouraged to contact the Canadian Retina Society (www.crssrc.ca) for further information and guidance on referral to telescreening programs.
  6 in total

1.  Excerpt from the Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of diabetic retinopathy.

Authors:  Philip Hooper; Marie Carole Boucher; Alan Cruess; Keith G Dawson; Walter Delpero; Mark Greve; Vladimir Kozousek; Wai-Ching Lam; David A L Maberley
Journal:  Can J Ophthalmol       Date:  2017-11       Impact factor: 1.882

2.  Tele-Ophthalmology for Age-Related Macular Degeneration and Diabetic Retinopathy Screening: A Systematic Review and Meta-Analysis.

Authors:  Atsushi Kawaguchi; Noha Sharafeldin; Aishwarya Sundaram; Sandy Campbell; Matthew Tennant; Christopher Rudnisky; Ezekiel Weis; Karim F Damji
Journal:  Telemed J E Health       Date:  2017-08-07       Impact factor: 3.536

3.  Identification of Diabetic Retinopathy and Ungradable Image Rate with Ultrawide Field Imaging in a National Teleophthalmology Program.

Authors:  Paolo S Silva; Mark B Horton; Dawn Clary; Drew G Lewis; Jennifer K Sun; Jerry D Cavallerano; Lloyd Paul Aiello
Journal:  Ophthalmology       Date:  2016-03-02       Impact factor: 12.079

4.  Evidence-based Canadian guidelines for tele-retina screening for diabetic retinopathy: recommendations from the Canadian Retina Research Network (CR2N) Tele-Retina Steering Committee.

Authors:  M C Boucher; J Qian; M H Brent; D T Wong; T Sheidow; R Duval; A Kherani; R Dookeran; D Maberley; A Samad; V Chaudhary
Journal:  Can J Ophthalmol       Date:  2020-02       Impact factor: 1.882

5.  Teleophthalmology for first nations clients at risk of diabetic retinopathy: a mixed methods evaluation.

Authors:  Julie Kim; D Dean Driver
Journal:  JMIR Med Inform       Date:  2015-02-23

Review 6.  Incidence of sight-threatening diabetic retinopathy in people with Type 2 diabetes mellitus and numbers needed to screen: a systematic review.

Authors:  Y Groeneveld; D Tavenier; J W Blom; B C P Polak
Journal:  Diabet Med       Date:  2019-03-12       Impact factor: 4.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.